Bayer Aktiengesellschaft (ETR:BAYN)
44.56
+0.39 (0.88%)
At close: Jan 23, 2026
Bayer Aktiengesellschaft Employees
Bayer Aktiengesellschaft had 91,864 employees as of December 31, 2024. The number of employees decreased by 5,067 or -5.23% compared to the previous year.
Employees
91,864
Change (1Y)
-5,067
Growth (1Y)
-5.23%
Revenue / Employee
€518,248
Profits / Employee
€2,237
Market Cap
43.77B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 91,864 | -5,067 | -5.23% |
| Dec 31, 2023 | 96,931 | -991 | -1.01% |
| Dec 31, 2022 | 97,922 | 1,972 | 2.06% |
| Dec 31, 2021 | 95,950 | -5 | -0.01% |
| Dec 31, 2020 | 95,955 | -2,782 | -2.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 176,486 |
| Fresenius Medical Care AG | 111,513 |
| Siemens Healthineers AG | 73,840 |
| Merck KGaA | 59,020 |
| Fielmann Group AG | 24,363 |
| Sartorius Aktiengesellschaft | 13,528 |
| Carl Zeiss Meditec AG | 5,784 |
| SCHOTT Pharma AG & Co. KGaA | 4,811 |
Bayer Aktiengesellschaft News
- 3 days ago - Bayer Announces FDA's Orphan Drug Designation For OpCT-001 To Treat Retinitis Pigmentosa - Nasdaq
- 5 days ago - Bayer Shares Jump as Supreme Court Agrees to Review Key Roundup Case - Nasdaq
- 5 days ago - EQS-PVR: Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 5 days ago - Bayer and Vanderbilt University Medical Center to Advance Treatments for Cardiovascular and Kidney Diseases - Business Wire
- 6 days ago - Bayer: Timing Upside In 2025, More Upside Possible But Risky In 2026E (Downgrade) - Seeking Alpha
- 6 days ago - Bayer Shares Rise After U.S Supreme Court Agrees to Review Roundup Case - The Wall Street Journal
- 8 days ago - Bayer : U.S. Supreme Court To Review Durnell Case In Roundup Litigation - Nasdaq
- 8 days ago - Supreme Court to hear Bayer's appeal to block thousands of Roundup weedkiller lawsuits - New York Post